Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Non-Small Cell Lung Carcinoma
|
712 | 0.568 | 0.560 | 7 | 55191822 | missense variant | T/A;G | snv | 0.800 | 0.983 | 176 | 2004 | 2020 | ||||||
Neoplasms
|
1644 | 0.568 | 0.560 | 7 | 55191822 | missense variant | T/A;G | snv | 0.100 | 0.933 | 60 | 2009 | 2019 | ||||||
Adenocarcinoma of lung (disorder)
|
563 | 0.568 | 0.560 | 7 | 55191822 | missense variant | T/A;G | snv | 0.100 | 1.000 | 58 | 2005 | 2020 | ||||||
Malignant neoplasm of lung
|
1142 | 0.568 | 0.560 | 7 | 55191822 | missense variant | T/A;G | snv | 0.100 | 0.975 | 40 | 2005 | 2019 | ||||||
Adenocarcinoma
|
168 | 0.568 | 0.560 | 7 | 55191822 | missense variant | T/A;G | snv | 0.100 | 0.941 | 34 | 2005 | 2020 | ||||||
Carcinoma of lung
|
1204 | 0.568 | 0.560 | 7 | 55191822 | missense variant | T/A;G | snv | 0.100 | 0.968 | 31 | 2006 | 2019 | ||||||
Primary malignant neoplasm of lung
|
981 | 0.568 | 0.560 | 7 | 55191822 | missense variant | T/A;G | snv | 0.100 | 0.968 | 31 | 2006 | 2019 | ||||||
Metastatic non-small cell lung cancer
|
11 | 0.568 | 0.560 | 7 | 55191822 | missense variant | T/A;G | snv | 0.100 | 1.000 | 12 | 2013 | 2019 | ||||||
Lung Neoplasms
|
39 | 0.568 | 0.560 | 7 | 55191822 | missense variant | T/A;G | snv | 0.060 | 1.000 | 6 | 2012 | 2019 | ||||||
Metastatic malignant neoplasm to brain
|
28 | 0.568 | 0.560 | 7 | 55191822 | missense variant | T/A;G | snv | 0.050 | 1.000 | 5 | 2010 | 2018 | ||||||
Adenocarcinoma of lung, stage IV
|
6 | 0.568 | 0.560 | 7 | 55191822 | missense variant | T/A;G | snv | 0.040 | 1.000 | 4 | 2013 | 2019 | ||||||
Malignant Neoplasms
|
1641 | 0.568 | 0.560 | 7 | 55191822 | missense variant | T/A;G | snv | 0.040 | 1.000 | 4 | 2009 | 2017 | ||||||
MYELOPROLIFERATIVE DISORDER, CHRONIC, WITH EOSINOPHILIA
|
5 | 0.568 | 0.560 | 7 | 55191822 | missense variant | T/A;G | snv | 0.040 | 1.000 | 4 | 2012 | 2017 | ||||||
Neoplasm Metastasis
|
327 | 0.568 | 0.560 | 7 | 55191822 | missense variant | T/A;G | snv | 0.040 | 1.000 | 4 | 2012 | 2018 | ||||||
Progressive cGVHD
|
40 | 0.568 | 0.560 | 7 | 55191822 | missense variant | T/A;G | snv | 0.040 | 1.000 | 4 | 2011 | 2019 | ||||||
Progressive Neoplastic Disease
|
40 | 0.568 | 0.560 | 7 | 55191822 | missense variant | T/A;G | snv | 0.040 | 1.000 | 4 | 2011 | 2019 | ||||||
Squamous cell carcinoma
|
257 | 0.568 | 0.560 | 7 | 55191822 | missense variant | T/A;G | snv | 0.040 | 1.000 | 4 | 2013 | 2016 | ||||||
Carcinogenesis
|
355 | 0.568 | 0.560 | 7 | 55191822 | missense variant | T/A;G | snv | 0.030 | 0.667 | 3 | 2012 | 2016 | ||||||
Metastatic Lung Adenocarcinoma
|
10 | 0.568 | 0.560 | 7 | 55191822 | missense variant | T/A;G | snv | 0.030 | 1.000 | 3 | 2014 | 2018 | ||||||
Metastatic Malignant Neoplasm to the Leptomeninges
|
9 | 0.568 | 0.560 | 7 | 55191822 | missense variant | T/A;G | snv | 0.030 | 1.000 | 3 | 2009 | 2019 | ||||||
Pleural Effusion, Malignant
|
6 | 0.568 | 0.560 | 7 | 55191822 | missense variant | T/A;G | snv | 0.030 | 1.000 | 3 | 2011 | 2015 | ||||||
Primary malignant neoplasm
|
1374 | 0.568 | 0.560 | 7 | 55191822 | missense variant | T/A;G | snv | 0.030 | 1.000 | 3 | 2012 | 2017 | ||||||
Small cell carcinoma of lung
|
125 | 0.568 | 0.560 | 7 | 55191822 | missense variant | T/A;G | snv | 0.030 | 1.000 | 3 | 2007 | 2013 | ||||||
Adenocarcinoma, Tubular
|
3 | 0.568 | 0.560 | 7 | 55191822 | missense variant | T/A;G | snv | 0.020 | 1.000 | 2 | 2007 | 2018 | ||||||
Breast Carcinoma
|
2793 | 0.568 | 0.560 | 7 | 55191822 | missense variant | T/A;G | snv | 0.020 | 1.000 | 2 | 2013 | 2015 |